Embecta Corp.
EMBCNASDAQHealthcareMedical Instruments & Supplies
As of Oct 23, 2026 close
- Market cap
- $392.62M
- P/E (TTM)
- 4.49
- Forward P/E
- 4.40
- Dividend yield
- 4.66%
- 52-week range
- $2.77$14.91
- Volume (live)
- -
- Avg. volume (3M)
- 957.43K
Embecta (EMBC) Stock Price & Financial Analysis
Embecta Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $6.69 - $6.88 |
|---|---|
| 52-Week High | $14.91 |
| 52-Week Low | $2.77 |
| Open | $6.77 |
| Volume (last close) | 717.00K |
| Average Volume (3M) | 957.43K |
| Revenue (TTM) | 1.02B |
|---|---|
| Net Income (TTM) | 87.50M |
| Free Cash Flow (TTM) | 164.60M |
| EPS (TTM) | $1.49 |
| Profit Margin | 8.59% |
| Operating Margin | 25.60% |
| Annual Dividend | $0.32 |
|---|---|
| Dividend Yield | 4.66% |
| Payout Ratio | 21.51% |
| Last Dividend Ex-Date | Aug 27, 2026 |
| Market Cap | 392.62M |
|---|---|
| Shares Outstanding | 58.51M |
| P/E Ratio (TTM) | 4.49 |
| Forward P/E | 4.40 |
| Price to Sales (P/S) | 0.39 |
| Price to Book (P/B) | -0.64 |
| EV/EBITDA | 5.94 |
| 50-Day MA | $5.50 |
|---|---|
| 200-Day MA | $6.67 |
| 1-Year Change | −51.49% |
Source: Market prices and company fundamentals. Data as of Oct 23, 2026. Data sources and methodology
Embecta at a Glance
As of the Oct 23, 2026 close, Embecta (EMBC) has a market capitalization of $392.62M. The stock trades at 4.5× trailing earnings, 4.4× forward earnings and 0.4× sales. Over the trailing twelve months it earned $87.50M on revenue of $1.02B (a 8.6% profit margin) and generated $164.60M of free cash flow. Revenue fell 7.6% year over year.
As of its latest reported balance sheet, it holds $214.70M in cash and securities against $1.50B of debt, a net debt position of $1.29B.
Embecta pays a quarterly dividend totaling $0.32 per share a year, a 4.66% yield at the Oct 23, 2026 close, with a 22% payout ratio.
The share price is down 51.5% over the past year. At $6.71 (the Oct 23, 2026 close) it sits within its 52-week range of $2.77 to $14.91, above its 200-day moving average of $6.67.
Based on 1 professional analyst rating from the past 90 days, the consensus is Buy.
Frequently Asked Questions About Embecta
What is the current stock price for EMBC?
As of the Oct 23, 2026 close, EMBC stock trades at $6.71. The 52-week range is $2.77–$14.91, with a day range of $6.69–$6.88.
What is the P/E ratio for EMBC?
As of the Oct 23, 2026 close, Embecta's trailing twelve-month (TTM) P/E ratio is 4.5, meaning investors pay $4.5 for every $1 of annual earnings. The forward P/E is 4.4, reflecting analyst expectations for future earnings. Embecta operates in the Healthcare sector.
Does EMBC pay dividends?
Yes, Embecta pays a 4.66% annual dividend yield as of the Oct 23, 2026 close ($0.32 per share a year). The trailing twelve-month payout ratio is 21.5%. The most recent ex-dividend date was August 27, 2026.
What do analysts recommend for EMBC?
Based on ratings from 1 professional analyst over the last 90 days, the consensus for EMBC is Buy.
What is the market cap of EMBC?
As of the Oct 23, 2026 close, Embecta's market capitalization is $392.6M, classifying it as a small-cap company. Embecta operates in the Healthcare sector within the Medical Instruments & Supplies industry.